IL17A and psoriasis: The TNF-α, MAPK, HIF-1α, and IL-17 signaling pathways were highly involved in the PPI network of 36 key targets of SHTLS, which are commonly recognized as major pathological features in the development of psoriasis (Figure 3 and Figure 4).